NIH-funded research NIH-funded research

Using immune checkpoint inhibitors to manage pain

Official title: Targeting checkpoint inhibitors for pain control

Funded at Duke University · NIH-10771904 · Data updated 2026-11-12

This study is looking at how certain proteins in the immune system, called PD-L1 and PD-1, might affect how well pain is managed and how opioids work, using specially modified mice to learn more about pain in different situations.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 21, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$2,569,851
NIH project number1RF1NS131812-01A1
Project IDNIH-10771904 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from chronic pain conditions, such as neuropathic pain or cancer-related pain.

Less likely to help

Patients who do not experience chronic pain or those who are not responsive to opioid analgesics may not benefit from this research.

What this research studies

This research investigates how immune checkpoint proteins, specifically PD-L1 and PD-1, influence pain control and the effectiveness of opioid analgesics. By utilizing genetically modified mice, the study aims to understand the role of these proteins in both normal and pathological pain conditions. The researchers will explore how the PD-L1/PD-1 pathway affects pain signaling in various contexts, including inflammatory and neuropathic pain. This could lead to new therapeutic strategies for pain management by targeting these immune pathways.

Why it matters

Potential benefit: If successful, this research could provide new methods for controlling pain, potentially reducing reliance on opioids and improving patient quality of life.

How similar studies have gone: Previous research has shown promise in using immune checkpoint inhibitors for various conditions, but this specific application for pain management is relatively novel.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Ji, Ru-Rong — Duke University
  • Study coordinator: Ji, Ru-Rong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.